OC
Oarsman Capital’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,317
| Closed | -$29K | – | 775 |
|
|
2024
Q4 | $29K | Buy |
+1,317
| New | +$29K | 0.01% | 540 |
|
|
2019
Q2 | – | Sell |
-10,517
| Closed | -$165K | – | 181 |
|
|
2019
Q1 | $165K | Sell |
10,517
-780
| -7% | -$12.2K | 0.08% | 169 |
|
|
2018
Q4 | $174K | Sell |
11,297
-550
| -5% | -$8.47K | 0.09% | 166 |
|
|
2018
Q3 | $255K | Buy |
11,847
+1,090
| +10% | +$23.5K | 0.1% | 160 |
|
|
2018
Q2 | $262K | Sell |
10,757
-1,400
| -12% | -$34.1K | 0.12% | 151 |
|
|
2018
Q1 | $208K | Sell |
12,157
-1,892
| -13% | -$32.4K | 0.09% | 170 |
|
|
2017
Q4 | $266K | Sell |
14,049
-3,715
| -21% | -$70.3K | 0.11% | 160 |
|
|
2017
Q3 | $313K | Sell |
17,764
-43,128
| -71% | -$760K | 0.13% | 147 |
|
|
2017
Q2 | $2.02M | Buy |
60,892
+6,432
| +12% | +$214K | 0.92% | 36 |
|
|
2017
Q1 | $1.75M | Buy |
54,460
+15,588
| +40% | +$500K | 0.81% | 39 |
|
|
2016
Q4 | $1.41M | Sell |
38,872
-967
| -2% | -$35.1K | 0.91% | 36 |
|
|
2016
Q3 | $1.83M | Buy |
39,839
+1,553
| +4% | +$71.5K | 0.93% | 35 |
|
|
2016
Q2 | $1.92M | Buy |
38,286
+5,851
| +18% | +$294K | 1% | 32 |
|
|
2016
Q1 | $1.74M | Buy |
32,435
+855
| +3% | +$45.8K | 0.92% | 39 |
|
|
2015
Q4 | $2.07M | Buy |
31,580
+6,026
| +24% | +$396K | 1.16% | 23 |
|
|
2015
Q3 | $1.44M | Sell |
25,554
-360
| -1% | -$20.3K | 0.85% | 39 |
|
|
2015
Q2 | $1.53M | Buy |
25,914
+335
| +1% | +$19.8K | 1.04% | 28 |
|
|
2015
Q1 | $1.59M | Buy |
25,579
+310
| +1% | +$19.3K | 1.1% | 28 |
|
|
2014
Q4 | $1.45M | Sell |
25,269
-10
| -0% | -$575 | 1.05% | 30 |
|
|
2014
Q3 | $1.36M | Buy |
25,279
+145
| +0.6% | +$7.8K | 1% | 31 |
|
|
2014
Q2 | $1.32M | Buy |
25,134
+505
| +2% | +$26.5K | 0.96% | 31 |
|
|
2014
Q1 | $1.3M | Sell |
24,629
-355
| -1% | -$18.8K | 1% | 29 |
|
|
2013
Q4 | $1M | Sell |
24,984
-5,895
| -19% | -$236K | 0.8% | 43 |
|
|
2013
Q3 | $1.17M | Buy |
30,879
+1,965
| +7% | +$74.3K | 1.02% | 30 |
|
|
2013
Q2 | $1.13M | Buy |
+28,914
| New | +$1.13M | 1.07% | 31 |
|